Evidence map›Paper›PMID 39432499›Full record

ArticleDatabase : the journal of biological databases and curation2024

Is metadata of articles about COVID-19 enough for multilabel topic classification task?

Shuo Xu, Yuefu Zhang, Liang Chen, Xin An

Abstract read
In one paragraph

Article in Database : the journal of biological databases and curation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuo XuCollege of Economics and Management, Beijing University of Technology, No. 100 PingLeYuan, Chaoyang District, Beijing 100124, P.R. China.ORCID 0000-0002-8602-1819
Yuefu ZhangCollege of Economics and Management, Beijing University of Technology, No. 100 PingLeYuan, Chaoyang District, Beijing 100124, P.R. China.
Liang ChenInstitute of Scientific and Technical Information of China, No. 15 Fuxing Road, Haidian District, Beijing 100038, P.R. China.ORCID 0000-0002-3235-9806
Xin AnSchool of Economics and Management, Beijing Forestry University, No. 35 Qinghua East Road, Haidian District, Beijing 100083, P.R. China.

Funding

National Natural Science Foundation of China 72004012 72074014
6 · The paper itself

Abstract

The ever-increasing volume of COVID-19-related articles presents a significant challenge for the manual curation and multilabel topic classification of LitCovid. For this purpose, a novel multilabel topic classification framework is developed in this study, which considers both the correlation and imbalance of topic labels, while empowering the pretrained model. With the help of this framework, this study devotes to answering the following question: Do full texts, MeSH (Medical Subject Heading), and biological entities of articles about COVID-19 encode more discriminative information than metadata (title, abstract, keyword, and journal name)? From extensive experiments on our enriched version of the BC7-LitCovid corpus and Hallmarks of Cancer corpus, the following conclusions can be drawn. Our framework demonstrates superior performance and robustness. The metadata of scientific publications about COVID-19 carries valuable information for multilabel topic classification. Compared to biological entities, full texts and MeSH can further enhance the performance of our framework for multilabel topic classification, but the improved performance is very limited. Database URL: https://github.com/pzczxs/Enriched-BC7-LitCovid.

Indexed as

COVID-19MetadataSARS-CoV-2Data CurationHumansMedical Subject Headings

Identifiers

PMID39432499
PMCPMC11492800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.